Next Article in Journal
Podophyllotoxin Content Analysis of Linum album Kotschy ex Boiss. Subjected to Short-Term Potassium Deficiency Stress
Previous Article in Journal
Broad-Spectrum Activity of Antimicrobial Peptoids
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Chalcones as Potential Inhibitors of Pancreatic Lipase †

1
Associated Laboratory for Green Chemistry (LAQV), Network of Chemistry and Technology (REQUIMTE), Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
2
Center for Research in Chemical Synthesis (CISQ), Department of Chemistry, Faculty of Science and Technology, University of La Rioja, 26006 Logroño, Spain
3
Applied Molecular Biosciences Unit (UCIBIO), Network of Chemistry and Technology (REQUIMTE), Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
4
Associated Laboratory for Green Chemistry (LAQV), Network of Chemistry and Technology (REQUIMTE), Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
*
Authors to whom correspondence should be addressed.
Presented at the 8th International Electronic Conference on Medicinal Chemistry, 1–30 November 2022; Available online: https://ecmc2022.sciforum.net/.
Med. Sci. Forum 2022, 14(1), 116; https://doi.org/10.3390/ECMC2022-13413
Published: 1 November 2022
(This article belongs to the Proceedings of The 8th International Electronic Conference on Medicinal Chemistry)

Abstract

:
Obesity is a global disease that has been escalating to epidemic proportions over the past years. A recent report from World Obesity Federation predicts that, in 2030, 1 billion people will be obese. Thus, it is mandatory to develop new therapeutic options that can manage and control obesity. One of the most promising research paths is the inhibition of pancreatic lipase (PL), responsible for the hydrolysis of 50 to 70% of total dietary triglycerides. Chalcones are the precursors of flavonoids, consisting of two benzene rings connected by a three-carbon α, β-unsaturated carbonyl structure. The goal of the present work was to evaluate the activity of seven chalcones with hydroxy (OH) and chloride (Cl) substituents, as potential inhibitors of PL. For this purpose, spectrophotometric and fluorometric microanalysis systems were used, based on the enzymatic metabolization of p-nitrophenyl butyrate and 4-methylumbeliferyl oleate, respectively. The obtained results showed that chalcones inhibit PL activity, and that the fluorometric method can reach higher inhibition rates with fewer compounds than the spectrophotometric method. These findings bring new insights into the structure design for the modulation of PL, but further studies are still needed to further explore these compounds as potential anti-obesity molecules.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ECMC2022-13413/s1.

Author Contributions

Conceptualization, S.R., A.T.R. and E.F.; methodology, S.R.; validation, S.R., A.T.R. and E.F.; formal analysis, S.R., Á.T., A.T.R. and E.F.; investigation, S.R. and Á.T.; writing—original draft preparation, S.R. and Á.T.; writing—review and editing, A.T.R., M.F., F.C., A.S. and E.F.; supervision, F.C., A.S. and E.F.; project administration, E.F.; funding acquisition, E.F. All authors have read and agreed to the published version of the manuscript.

Funding

This work received financial support from PT national funds (FCT/MCTES, Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior) through the projects UIDB/50006/2020 and UIDP/50006/2020 and throught project EXPL/MED-QUI/0815/2021, entitled “Screening and pharmacological characterization of flalavonoids as lead compounds for obesity treatment”. S.R. thanks FCT and ESF (European Social Fund) through NORTE 2020 (Programa Operacional Regional do Norte) for her PhD grant ref. 2021.07176.BD. A.T.R. thanks to FCT for the funding through the project PTDC/MED-QUI/29243/2017. M.F. thanks FCT for funding through the Scientific Employment Stimulus—Individual Call (2020.04126.CEECIND/CP1596/CT0006) and also LAQV-REQUIMTE for her contract under the reference LA/P/0008/2020.

Institutional Review Board Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rocha, S.; Tomé, Á.; Rufino, A.T.; Freitas, M.; Carvalho, F.; Silva, A.; Fernandes, E. Chalcones as Potential Inhibitors of Pancreatic Lipase. Med. Sci. Forum 2022, 14, 116. https://doi.org/10.3390/ECMC2022-13413

AMA Style

Rocha S, Tomé Á, Rufino AT, Freitas M, Carvalho F, Silva A, Fernandes E. Chalcones as Potential Inhibitors of Pancreatic Lipase. Medical Sciences Forum. 2022; 14(1):116. https://doi.org/10.3390/ECMC2022-13413

Chicago/Turabian Style

Rocha, Sílvia, Álvaro Tomé, Ana Teresa Rufino, Marisa Freitas, Félix Carvalho, Artur Silva, and Eduarda Fernandes. 2022. "Chalcones as Potential Inhibitors of Pancreatic Lipase" Medical Sciences Forum 14, no. 1: 116. https://doi.org/10.3390/ECMC2022-13413

Article Metrics

Back to TopTop